Larvol Delta - Cognition-Therapeutics-Doses-First-Patient-with-Dementia-with-Lewy-Bodies-in-Phase-2-Clinical-Study-of-CT1812

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2022/06/23/2467882/0/en/Cognition-Therapeutics-Doses-First-Patient-with-Dementia-with-Lewy-Bodies-in-Phase-2-Clinical-Study-of-CT1812.html

Jun 23, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next